SEARCH

SEARCH BY CITATION

References

  • 1
    Okada H, Kuhn C, Feillet H, Bach JF. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010;1601:19.
  • 2
    Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin Exp Allergy 2006;364:40225.
  • 3
    Worldwide variation in prevalence of symptoms of asthma allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The international study of asthma and allergies in childhood (ISAAC) steering committee. Lancet 1998;3519111:122532.
  • 4
    Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;23:11925.
  • 5
    Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;843:22343.
  • 6
    Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 2002;1151:1829.
  • 7
    Kramer MS, Matush L, Bogdanovich N, Dahhou M, Platt RW, Mazer B. The low prevalence of allergic disease in Eastern Europe: are risk factors consistent with the hygiene hypothesis? Clin Exp Allergy 2009;395:70816.
  • 8
    Renz H, Herz U. The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur Respir J 2002;191:15871.
  • 9
    Seiskari T, Kondrashova A, Viskari H, Kaila M, Haapala AM, Aittoniemi J, et al. Allergic sensitization and microbial load–a comparison between Finland and Russian Karelia. Clin Exp Immunol 2007;1481:4752.
  • 10
    Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002;5112:335361.
  • 11
    Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004;3649446:1699700.
  • 12
    Akerblom HK, Reunanen A. The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in northern Europe. Diabetes Care 1985;8(Suppl 1):106.
  • 13
    Harjutsalo V, Sjoberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;3719626:177782.
  • 14
    Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005;265:2607.
  • 15
    Lim RH, Kobzik L, Dahl M. Risk for asthma in offspring of asthmatic mothers versus fathers: a meta-analysis. PLoS ONE 2010;54:e10134.
  • 16
    Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;2996710:125960.
  • 17
    Braun-Fahrlander C, Gassner M, Grize L, Neu U, Sennhauser FH, Varonier HS, et al. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss study on childhood allergy and respiratory symptoms with respect to air pollution. Clin Exp Allergy 1999;291:2834.
  • 18
    Riedler J, Eder W, Oberfeld G, Schreuer M. Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 2000;302:194200.
  • 19
    Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000;302:18793.
  • 20
    Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 2002;2888:96372.
  • 21
    Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 2004;3287450:1223.
  • 22
    Shaheen SO, Aaby P, Hall AJ, Barker DJ, Heyes CB, Shiell AW, et al. Measles and atopy in Guinea-Bissau. Lancet 1996;3479018:17926.
  • 23
    Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis a virus. BMJ 1997;3147086:9991003.
  • 24
    Janson C, Asbjornsdottir H, Birgisdottir A, Sigurjonsdottir RB, Gunnbjornsdottir M, Gislason D, et al. The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia, and Sweden. J Allergy Clin Immunol 2007;1203:6739.
  • 25
    Illi S, von Mutius E, Lau S, Bergmann R, Niggemann B, Sommerfeld C, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001;3227283:3905.
  • 26
    von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998;3519106:8626.
  • 27
    Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011;112:11930.
  • 28
    Vercelli D. Mechanisms of the hygiene hypothesis–molecular and otherwise. Curr Opin Immunol 2006;186:7337.
  • 29
    Nordstrom I, Rudin A, Adlerberth I, Wold A, Saalman R, Hesselmar B, et al. Infection of infants with human herpesvirus type 6 may be associated with reduced allergic sensitization and T-helper type 2 development. Clin Exp Allergy 2010;406:88290.
  • 30
    Saghafian-Hedengren S, Sverremark-Ekstrom E, Linde A, Lilja G, Nilsson C. Early-life EBV infection protects against persistent IgE sensitization. J Allergy Clin Immunol 2010;1252:4338.
  • 31
    Kaplan JL, Shi HN, Walker WA. The role of microbes in developmental immunologic programming. Pediatr Res 2011;696:46572.
  • 32
    Lemke H, Tanasa RI, Trad A, Lange H. Benefits and burden of the maternally-mediated immunological imprinting. Autoimmun Rev 2009;85:3949.
  • 33
    von Mutius E. Infection: friend or foe in the development of atopy and asthma? The epidemiological evidence. Eur Respir J 2001;185:87281.
  • 34
    Garcia-Marcos L, Suarez-Varela MM, Canflanca IM, Garrido JB, Quiros AB. Lopez-Silvarrey Varela A, et al. BCG immunization at birth and atopic diseases in a homogeneous population of Spanish schoolchildren. Int Arch Allergy Immunol 2005;1374:3039.
  • 35
    Hughes CH, Jones RC, Wright DE, Dobbs FF. A retrospective study of the relationship between childhood asthma and respiratory infection during gestation. Clin Exp Allergy 1999;2910:137881.
  • 36
    Calvani M, Alessandri C, Sopo SM, Panetta V, Tripodi S, Torre A, et al. Infectious and uterus related complications during pregnancy and development of atopic and nonatopic asthma in children. Allergy 2004;591:99106.
  • 37
    Xu B, Pekkanen J, Jarvelin MR, Olsen P, Hartikainen AL. Maternal infections in pregnancy and the development of asthma among offspring. Int J Epidemiol 1999;284:7237.
  • 38
    Xepapadaki P, Papadopoulos NG. Viral infections and allergies. Immunobiology 2007;2126:4539.
  • 39
    Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy–the first sign of childhood asthma? J Allergy Clin Immunol 2003;1111:6671.
  • 40
    Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood diabetes in Finland (DiMe) study group. Diabetes 1995;446:6527.
  • 41
    Hyoty H. Environmental causes: viral causes. Endocrinol Metab Clin North Am 2004;331:2744, viii.
  • 42
    Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998;47:7815.
  • 43
    Rook GA. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 2009;1261:311.
  • 44
    Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010;107:50113.
  • 45
    Diaz A, Allen JE. Mapping immune response profiles: the emerging scenario from helminth immunology. Eur J Immunol 2007;3712:331926.
  • 46
    Sjogren YM, Tomicic S, Lundberg A, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 2009;3912:184251.
  • 47
    Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003;91441:4855.
  • 48
    Tariq SM, Matthews SM, Hakim EA, Stevens M, Arshad SH, Hide DW. The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol 1998;1015:58793.
  • 49
    Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006;1182:51121.
  • 50
    Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax 1998;5311:92732.
  • 51
    Strachan DP. Family size, infection and atopy: the first decade of the ‘hygiene hypothesis’. Thorax 2000;55(Suppl 1):S210.
  • 52
    Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;293:3426.
  • 53
    Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007;2126:44152.
  • 54
    Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;3619372:186971.
  • 55
    Elmadfa I, Klein P, Meyer AL. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proc Nutr Soc 2010;693:41620.
  • 56
    Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003;31:1520.
  • 57
    Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997;2755296:779.
  • 58
    Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992;51:285322.
  • 59
    Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994;154:51642.
  • 60
    Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000;495:70811.
  • 61
    Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004;3292:38194.
  • 62
    Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003;335:143949.
  • 63
    Zaccone P, Burton O, Miller N, Jones FM, Dunne DW, Cooke A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 2009;394:1098107.
  • 64
    Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999;214:16976.
  • 65
    Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005;488:156575.
  • 66
    Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002;7623:12097111.
  • 67
    Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ, Vague P. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Eur J Immunol 1990;206:1297303.
  • 68
    Smith P, Fallon RE, Mangan NE, Walsh CM, Saraiva M, Sayers JR, et al. Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J Exp Med 2005;20210:131925.
  • 69
    Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 2005;1217:1294304.
  • 70
    Aumeunier A, Grela F, Ramadan A, Van Pham L, Bardel E. Gomez AE, et al. Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS ONE 2010;57:e11484.
  • 71
    van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000;3569243:17237.
  • 72
    Sheikh A, Smeeth L, Hubbard R. There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J Allergy Clin Immunol 2003;1111:1315.
  • 73
    Rook GA, Brunet LR. Old friends for breakfast. Clin Exp Allergy 2005;357:8412.
  • 74
    Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;1182:22941.
  • 75
    Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009;2271:22133.
  • 76
    Yazdanbakhsh M, Matricardi PM. Parasites and the hygiene hypothesis: regulating the immune system? Clin Rev Allergy Immunol 2004;261:1524.
  • 77
    Flohr C, Tuyen LN, Lewis S, Quinnell R, Minh TT, Liem HT, et al. Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: A cross-sectional study. J Allergy Clin Immunol 2006;1186:130511.
  • 78
    Mpairwe H, Webb EL, Muhangi L, Ndibazza J, Akishule D, Nampijja M, et al. Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatr Allergy Immunol 2011;223:30512.
  • 79
    Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;3579262:10769.
  • 80
    Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002;86:6259.
  • 81
    Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001;1073:5314.
  • 82
    Burton OT, Gibbs S, Miller N, Jones FM, Wen L, Dunne DW, et al. Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigens. Eur J Immunol 2010;408:22219.
  • 83
    Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004;1262:5208.
  • 84
    Mardini HE, Gregory KJ, Nasser M, Selby L, Arsenescu R, Winter TA, et al. Gastroduodenal Crohn's disease is associated with NOD2/CARD15 gene polymorphisms, particularly L1007P homozygosity. Dig Dis Sci 2005;5012:231622.
  • 85
    Kabesch M, Peters W, Carr D, Leupold W, Weiland SK, von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 2003;1114:8137.
  • 86
    Ege MJ, Bieli C, Frei R, van Strien RT, Riedler J, Ublagger E, et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006;1174:81723.
  • 87
    Hori S, Carvalho TL, Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002;325:128291.
  • 88
    Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, et al. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 2002;16911:6298308.
  • 89
    Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002;4206915:5027.
  • 90
    Peng H, Hagopian W. Environmental factors in the development of type 1 diabetes. Rev Endocr Metab Disord 2006;73:14962.
  • 91
    Bach JF. Infections and autoimmune diseases. J Autoimmun 2005;25(Suppl):7480.
  • 92
    Kondrashova A, Reunanen A, Romanov A, Karvonen A, Viskari H, Vesikari T, et al. A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 2005;371:6772.
  • 93
    Podar T, Laporte RE, Tuomilehto J, Shubnikov E. Risk of childhood type 1 diabetes for Russians in Estonia and Siberia. Int J Epidemiol 1993;222:2627.
  • 94
    Patterson CC, Dahlquist G, Soltesz G, Green A. Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 2001;44(Suppl 3):B916.
  • 95
    Rytkonen M, Ranta J, Tuomilehto J, Karvonen M. Bayesian analysis of geographical variation in the incidence of type I diabetes in Finland. Diabetologia 2001;44(Suppl 3):B3744.
  • 96
    Nejentsev S, Koskinen S, Sjoroos M, Reijonen H, Schwartz EI, Kovalchuk L, et al. Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region. Tissue Antigens 1998;525:4737.
  • 97
    Kondrashova A, Viskari H, Kulmala P, Romanov A, Ilonen J, Hyoty H, et al. Signs of beta-cell autoimmunity in nondiabetic schoolchildren: a comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate. Diabetes Care 2007;301:95100.
  • 98
    Mrena S, Savola K, Kulmala P, Akerblom HK, Knip M. Natural course of preclinical type 1 diabetes in siblings of affected children. Acta Paediatr 2003;9212:140310.
  • 99
    Kukko M, Kimpimaki T, Korhonen S, Kupila A, Simell S, Veijola R, et al. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2005;905:27127.
  • 100
    Yu J, Yu L, Bugawan TL, Erlich HA, Barriga K, Hoffman M, et al. Transient antiislet autoantibodies: infrequent occurrence and lack of association with ‘genetic’ risk factors. J Clin Endocrinol Metab 2000;857:24218.
  • 101
    Kimpimaki T, Kulmala P, Savola K, Vahasalo P, Reijonen H, Ilonen J, et al. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood diabetes in Finland study group. J Clin Endocrinol Metab 2000;853:112632.
  • 102
    Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes 1999;483:4608.
  • 103
    LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, et al. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington state diabetes prediction study. Diabetes Care 2002;253:50511.
  • 104
    Batstra MR, Petersen JS, Bruining GJ, Grobbee DE, de Man SA, Molenaar JL, et al. Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands. Hum Immunol 2001;6210:110610.
  • 105
    Marciulionyte D, Williams AJ, Bingley PJ, Urbonaite B, Gale EA. A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes. Diabetologia 2001;441:1621.
  • 106
    Kondrashova A, Mustalahti K, Kaukinen K, Viskari H, Volodicheva V, Haapala AM, et al. Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med 2008;403:22331.
  • 107
    Kondrashova A, Viskari H, Haapala AM, Seiskari T, Kulmala P, Ilonen J, et al. Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 2008;933:72934.
  • 108
    Viskari H, Ludvigsson J, Uibo R, Salur L, Marciulionyte D, Hermann R, et al. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol 2004;724:6107.
  • 109
    Seiskari T, Kondrashova A, Tauriainen S, Knip M, Viskari H, Haapala AM, et al. Role of enterovirus infections in IgE sensitization. J Med Virol 2012;842:26871.
  • 110
    Seiskari T, Viskari H, Kondrashova A, Haapala AM, Ilonen J, Knip M, et al. Co-occurrence of allergic sensitization and type 1 diabetes. Ann Med 2010;425:3529.
  • 111
    Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab 2005;166:2616.
  • 112
    Viskari H, Kondrashova A, Koskela P, Knip M, Hyoty H. Circulating vitamin D concentrations in two neighboring populations with markedly different incidence of type 1 diabetes. Diabetes Care 2006;296:14589.
  • 113
    Hasunen K, Kalavainen M, Keinonen H, Lagström H, Lyytikäinen A, Nurttila A, et al. Nutrition recommendations for infants and young children as well as pregnant and breastfeeding mothers. Vol. 11. Helsinki: Ministry of Social Affairs and Health, 2004. (in Finnish)
  • 114
    Korovina NA, Zakharova IN, Cheburkin AV. A new view on D vitamins. Russ Med J 2000;8:4650. (in Russian)
  • 115
    Prophylaxis and treatment of rickets in young age children. In: Methodical Recommendations of the Ministry of Health of the Russian Federation. Moscow: Ministry of Health, 1990. (in Russian)
  • 116
    Pakarinen J, Hyvarinen A, Salkinoja-Salonen M, Laitinen S, Nevalainen A, Makela MJ, et al. Predominance of gram-positive bacteria in house dust in the low-allergy risk Russian Karelia. Environ Microbiol 2008;1012:331725.
  • 117
    Measures on the improvement of prophylaxis of parasitic diseases, Report No. 21. Moscow: Ministry of Health of the Russian Federation, 2001. (in Russian)
  • 118
    Strengthening actions under the prevention of parasitic diseases and elimination of malaria in the Russian Federation, resolution No. 94. Moscow: Ministry of Health of the Russian Federation, 2007. (in Russian)
  • 119
    Liu AH, Murphy JR. Hygiene hypothesis: fact or fiction? J Allergy Clin Immunol 2003;1113:4718.